Search results
Found 6782 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxfordshire-based SCAN pathway wins BMJ award
Awards and Appointments General
9 October 2020
Every year, the British Medical Journal (BMJ) runs a competition to find the cancer care team that has developed new approaches to improve cancer diagnosis and treatment. This year, six teams were shortlisted from across the UK and on the 7th October it was announced that the Oxfordshire-based SCAN pathway had won this year’s award.
COVID-19: examining theories for Africa’s low death rates
Coronavirus COVID-19 General
9 October 2020
BIPOC/BAME STEM Network – register your interest!
9 October 2020
Preventing opiod-related addiction harm after surgery
General Research
8 October 2020
An international group of experts have published guidance on how to prevent opioid-related harm in adult surgical patients.
Role-playing computer game helps players understand how vaccines work on a global scale
Coronavirus COVID-19 Public Engagement with Research Research
8 October 2020
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.
Prof. Ellie Barnes comments on the 2020 Nobel Prize for Medicine
General
7 October 2020
Prof Ellie Barnes (Nuffield Department of Medicine / DeLIVER lead) comments on the recent Nobel Prize in Medicine, awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of the Hepatitis C virus, a major global health problem and a cause of cancer
Patients with cirrhosis at increased risk of death from COVID-19, study finds
Coronavirus COVID-19 General Research
7 October 2020
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19.
Hospitalised COVID-19 patients shown to be younger and healthier than flu patients
Coronavirus COVID-19 General Research
6 October 2020
Patients hospitalised with COVID-19 were more likely male, younger and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a recent study published recently by the Observational Health Data Sciences and Informatics (OHDSI) community.
Circadian rhythm: liver gene helps body keep working smoothly after late nights and midnight snacks
General Research
6 October 2020
Sites of early dysfunction in Parkinson's identified
General Research
2 October 2020
A new collaborative study from the Oxford Parkinson’s Disease Centre has revealed that GABA transporters on astrocytes, the brain's lesser known yet critically important cells, support dopamine release and are sites of early dysfunction in parkinsonism.
New partnership with King Abdulaziz University aims to revolutionise drug discovery using artificial intelligence
General Research
1 October 2020
The University of Oxford and King Abdulaziz University (KAU) have partnered to create a new Centre for Artificial Intelligence and Precision Medicine.
New trial to treat Covid-19 in care homes using anti-TNF drug begins
Clinical Trials Coronavirus COVID-19 Research
30 September 2020
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.
Ambitious Oxford initiative launched to address graduate under-representation
General
30 September 2020
Oxford University and its colleges today announced a major new scholarship scheme for Black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.
Tiny brain “tweezers” could hold the key to treat Parkinson’s
General Research
29 September 2020
A collaborative study led by Oxford Parkinson’s Disease Centre has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson’s.
A million deaths from coronavirus: seven experts consider key questions
Coronavirus COVID-19 General
28 September 2020
Regular COVID-19 testing for groups most likely to spread the virus more efficient, cost-effective than random testing
Coronavirus COVID-19 General
28 September 2020
As COVID-19 infections begin to rise again, a novel testing strategy proposed by researchers at the University of Oxford at the start of the pandemic has become urgent once again.
Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
Coronavirus COVID-19 Innovation Research
28 September 2020
New research shows that, in a head-to-head comparison of five tests used to detect COVID-19 antibodies (known as ‘immunoassays’), an assay manufactured by Siemens and one developed by an academic partnership led by the University of Oxford had the most accurate results. The study is published in The Lancet Infectious Diseases.
Parkinson’s disease can affect the eyes – here’s what we know so far
General Research
28 September 2020